Literature DB >> 9852045

A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities.

C Boucheron1, S Dumon, S C Santos, R Moriggl, L Hennighausen, S Gisselbrecht, F Gouilleux.   

Abstract

STAT5A and STAT5B are two highly related transcription factors encoded by two distinct genes. STAT5A and STAT5B are activated by a broad range of cytokines and growth factors. Although they can be differentially activated, the functional difference between these two molecules relative to their structure is not known. Here we demonstrated that STAT5A and STAT5B homodimers have distinct DNA binding preferences. Chimeric STAT5 molecules allowed us to identify a region between amino acid 420 and 545 responsible for the DNA binding specificity. This region is located in the previously characterized DNA binding region of STAT proteins. Sequence comparison between STAT5A and STAT5B from different species showed a difference of 5 amino acids in the region 420-545 between STAT5A and STAT5B. Substitution of these amino acids demonstrated that a glycine residue at position 433 in STAT5B and a glutamic residue at a similar position in STAT5A determined the DNA binding specificity. These data indicate that STAT5A and STAT5B homodimers may have distinct function and probably regulate the expression of common as well as distinct genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852045     DOI: 10.1074/jbc.273.51.33936

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.

Authors:  E Soldaini; S John; S Moro; J Bollenbacher; U Schindler; W J Leonard
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.

Authors:  Jennifer A Cain; Zhifu Xiang; Julie O'Neal; Friederike Kreisel; AnnaLynn Colson; Hui Luo; Lothar Hennighausen; Michael H Tomasson
Journal:  Blood       Date:  2007-01-11       Impact factor: 22.113

3.  An SH2 domain model of STAT5 in complex with phospho-peptides define "STAT5 Binding Signatures".

Authors:  Eleonora Gianti; Randy J Zauhar
Journal:  J Comput Aided Mol Des       Date:  2015-03-10       Impact factor: 3.686

4.  Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer.

Authors:  Zhiyong Liao; Marja T Nevalainen
Journal:  Am J Transl Res       Date:  2010-11-21       Impact factor: 4.060

5.  Similarities and differences in the transcriptional control of expression of the mouse TSLP gene in skin epidermis and intestinal epithelium.

Authors:  Krishna Priya Ganti; Atish Mukherji; Milan Surjit; Mei Li; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

6.  Study on the STAT5A/AvaI polymorphism in Jersey cows and association with milk production traits.

Authors:  Cataldo Dario; Maria Selvaggi
Journal:  Mol Biol Rep       Date:  2011-03-09       Impact factor: 2.316

Review 7.  STAT heterodimers in immunity: A mixed message or a unique signal?

Authors:  Greg M Delgoffe; Dario A A Vignali
Journal:  JAKSTAT       Date:  2013-01-01

8.  Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.

Authors:  M Nieborowska-Skorska; M A Wasik; A Slupianek; P Salomoni; T Kitamura; B Calabretta; T Skorski
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

9.  Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells.

Authors:  Jennifer A Jenks; Scott Seki; Takahiro Kanai; Jennifer Huang; Alexander A Morgan; Renata C Scalco; Ruhi Nath; Robert Bucayu; Jan M Wit; Waleed Al-Herz; Dina Ramadan; Alexander A Jorge; Rosa Bacchetta; Vivian Hwa; Ron Rosenfeld; Kari C Nadeau
Journal:  Clin Immunol       Date:  2013-05-05       Impact factor: 3.969

10.  The STAT5b Pathway Defect and Autoimmunity.

Authors:  Takahiro Kanai; Jennifer Jenks; Kari Christine Nadeau
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.